Games released in 2025 are at the top of sales charts, GAMIVOs research shows
GAMIVO's analyses indicates that 60% of gamers prefer games released between 2021…
Curium Announces First Commercial Doses of PYLCLARI for Patients with Prostate Cancer in Poland
PYLCLARI® provides solutions to a wider patient group across Poland where there…
Press Release: Sanofi and Regenerons Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to…
Dupixent (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
Approval based on global Phase 3 program in children demonstrating Dupixent significantly…
DataGavel Announces Full Acquisition by Renvent Holdings as Platform Emerges as the Defense Bars Advantage
ROSWELL, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- DataGavel, the LegalTech platform…
Mawson Infrastructure Group Inc. Announces Compliance with Nasdaq Continued Listing Requirements
December 22, 2025 14:05 ET | Source: Mawson Infrastructure Group Inc. MIDLAND,…
CreditBlockchain Introduces Limited Ticket Distribution, Helping Fans Celebrate the Ultimate Sporting Event
New York, USA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- CreditBlockchain is giving…
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq:…
Biosplice Therapeutics Announces First Patient Dosed in InvestigatorInitiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD PlatinumResistant Ovarian Cancer
SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”),…
Alvotech announces European launch of first-in-market biosimilar to Simponi (golimumab) globally by partner Advanz Pharma
Introduction of AVT05 supported by NHS England tender award in the United…
